These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Stimulating pro-reparative immune responses to prevent adverse cardiac remodelling: consensus document from the joint 2019 meeting of the ESC Working Groups of cellular biology of the heart and myocardial function. Steffens S; Van Linthout S; Sluijter JPG; Tocchetti CG; Thum T; Madonna R Cardiovasc Res; 2020 Sep; 116(11):1850-1862. PubMed ID: 32396608 [TBL] [Abstract][Full Text] [Related]
5. Targeting the myocardial sodium-hydrogen exchange for treatment of heart failure. Morris K Expert Opin Ther Targets; 2002 Jun; 6(3):291-8. PubMed ID: 12223070 [TBL] [Abstract][Full Text] [Related]
6. Chronic administration of an endothelin-A receptor antagonist improves exercise capacity in rats with myocardial infarction-induced congestive heart failure. Miyauchi T; Fujimori A; Maeda S; Iemitsu M; Sakai S; Shikama H; Tanabe T; Matsuda M; Goto K; Yamaguchi I J Cardiovasc Pharmacol; 2004 Nov; 44 Suppl 1():S64-7. PubMed ID: 15838361 [TBL] [Abstract][Full Text] [Related]
7. β-Arrestin2 Improves Post-Myocardial Infarction Heart Failure via Sarco(endo)plasmic Reticulum Ca McCrink KA; Maning J; Vu A; Jafferjee M; Marrero C; Brill A; Bathgate-Siryk A; Dabul S; Koch WJ; Lymperopoulos A Hypertension; 2017 Nov; 70(5):972-981. PubMed ID: 28874462 [TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinases as input and output signals for post-myocardial infarction remodeling. Lindsey ML; Iyer RP; Jung M; DeLeon-Pennell KY; Ma Y J Mol Cell Cardiol; 2016 Feb; 91():134-40. PubMed ID: 26721597 [TBL] [Abstract][Full Text] [Related]
9. Pioglitazone, a peroxisome proliferator-activated receptor-gamma agonist, attenuates left ventricular remodeling and failure after experimental myocardial infarction. Shiomi T; Tsutsui H; Hayashidani S; Suematsu N; Ikeuchi M; Wen J; Ishibashi M; Kubota T; Egashira K; Takeshita A Circulation; 2002 Dec; 106(24):3126-32. PubMed ID: 12473562 [TBL] [Abstract][Full Text] [Related]
10. Molecular pathogenesis of myocardial remodeling and new potential therapeutic targets in chronic heart failure. Distefano G; Sciacca P Ital J Pediatr; 2012 Sep; 38():41. PubMed ID: 22971785 [TBL] [Abstract][Full Text] [Related]
11. Critical roles for the Fas/Fas ligand system in postinfarction ventricular remodeling and heart failure. Li Y; Takemura G; Kosai K; Takahashi T; Okada H; Miyata S; Yuge K; Nagano S; Esaki M; Khai NC; Goto K; Mikami A; Maruyama R; Minatoguchi S; Fujiwara T; Fujiwara H Circ Res; 2004 Sep; 95(6):627-36. PubMed ID: 15297380 [TBL] [Abstract][Full Text] [Related]
12. Ginseng reverses established cardiomyocyte hypertrophy and postmyocardial infarction-induced hypertrophy and heart failure. Moey M; Gan XT; Huang CX; Rajapurohitam V; Martínez-Abundis E; Lui EM; Karmazyn M Circ Heart Fail; 2012 Jul; 5(4):504-14. PubMed ID: 22576957 [TBL] [Abstract][Full Text] [Related]
13. New directions in strategies using cell therapy for heart disease. Itescu S; Schuster MD; Kocher AA J Mol Med (Berl); 2003 May; 81(5):288-96. PubMed ID: 12698252 [TBL] [Abstract][Full Text] [Related]
14. Long-term caspase inhibition ameliorates apoptosis, reduces myocardial troponin-I cleavage, protects left ventricular function, and attenuates remodeling in rats with myocardial infarction. Chandrashekhar Y; Sen S; Anway R; Shuros A; Anand I J Am Coll Cardiol; 2004 Jan; 43(2):295-301. PubMed ID: 14736452 [TBL] [Abstract][Full Text] [Related]
15. Selective PDE5A inhibition with sildenafil rescues left ventricular dysfunction, inflammatory immune response and cardiac remodeling in angiotensin II-induced heart failure in vivo. Westermann D; Becher PM; Lindner D; Savvatis K; Xia Y; Fröhlich M; Hoffmann S; Schultheiss HP; Tschöpe C Basic Res Cardiol; 2012 Nov; 107(6):308. PubMed ID: 23117837 [TBL] [Abstract][Full Text] [Related]
16. Effect of Chronic Heart Rate Reduction by I(f) Current Inhibitor Ivabradine on Left Ventricular Remodeling and Systolic Performance in Middle-Aged Rats With Postmyocardial Infarction Heart Failure. Dedkov EI; Bogatyryov Y; McCooey DS; Christensen LP; Weiss RM; Tomanek RJ J Cardiovasc Pharmacol Ther; 2015 May; 20(3):299-312. PubMed ID: 25287895 [TBL] [Abstract][Full Text] [Related]
17. Clinical aspects of left ventricular diastolic function assessed by Doppler echocardiography following acute myocardial infarction. Poulsen SH Dan Med Bull; 2001 Nov; 48(4):199-210. PubMed ID: 11767125 [TBL] [Abstract][Full Text] [Related]
18. Combination angiotensin converting enzyme and direct renin inhibition in heart failure following experimental myocardial infarction. Connelly KA; Advani A; Advani S; Zhang Y; Thai K; Thomas S; Krum H; Kelly DJ; Gilbert RE Cardiovasc Ther; 2013 Apr; 31(2):84-91. PubMed ID: 21884026 [TBL] [Abstract][Full Text] [Related]
19. [Comparative study on early application of the recipe for activating blood circulation and the recipe for supplementing qi for inhibiting left ventricular remodeling and apoptosis in rats with heart failure]. Zhao MJ; Wang SR; Li M; Wang ZT; Zhu LQ; Cui W; Lu XY Zhongguo Zhong Yao Za Zhi; 2007 Apr; 32(8):710-4. PubMed ID: 17608227 [TBL] [Abstract][Full Text] [Related]
20. Biologic rationale for the use of beta-blockers in the treatment of heart failure. Sabbah HN Heart Fail Rev; 2004 Apr; 9(2):91-7. PubMed ID: 15516856 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]